why choose us

First received: April 04, 2023

Clinical Trial: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetes Mellitus, Type 1

Study Type: INTERVENTIONAL


Official Title: Type 1 Diabetes Impacts of Semaglutide on Cardiovascular Outcomes

Brief Summary: This trial plans to learn more about the effects of a medication, semaglutide, on cardiovascular function, kidney function, and insulin sensitivity in adults with type 1 diabetes.This medication has been effective in reducing cardiovascular disease and diabetic kidney disease and improving glucose control and BMI in adults with type 2 diabetes.This study aims to look at how well the medication works in people with type 1 diabetes.Semaglutide is not approved by the FDA to be used in this way.These procedures are…

Read more